Competition in Minnesota and across the country is heating up among addiction treatment centers, with financial analysts predicting growth due to the large pool of patients currently going without treatment.
Last month, New Brighton-based Meridian Behavioral Health Services launched a new residential facility in Owatonna that caters to professionals who can pay $975 per day for treatment.
Offering equine therapy and fine cuisine in addition to standard treatments, the new facility puts Meridian up against longtime residential powerhouse Hazelden, which offers inpatient treatment for a similar list price in Center City.
Following a merger in 2014, Hazelden is expanding the Betty Ford Clinic brand in California while also investing in facilities here. There's activity elsewhere, too.
"Of the nearly 22.7 million people who needed treatment for substance addiction in 2013, only 2.5 million actually received it," wrote Ryan Daniels, a financial analyst with William Blair, in a research note last year. The increase in those needing treatment "is partly driven by nonmedical use of painkillers, from which an addict may move up to heroin as tolerance increases or painkillers become more difficult (and more costly) to find."
Daniels sized up the market in connection with the $69 million initial public offering of stock last fall from Tennessee-based American Addiction Centers. Just this month, another Tennessee firm — Acadia Healthcare — closed on a roughly $1 billion acquisition of CRC Health Group, a national player in addiction treatment circles.
"Relative to other health care services markets, substance abuse treatment is highly fragmented," Daniels wrote. "We believe the substance abuse treatment industry appears to be in the early innings of one of the largest remaining consolidation opportunities in health care."
Meridian Behavioral Health says it's the largest for-profit behavioral health company in Minnesota. For decades, that's meant a focus on patients with coverage from state-sponsored insurance programs, said Fran Sauvageau, the company's president and chief executive.